Teva terminates JV with P&G

Teva Pharmaceutical has announced it has terminated the PGT Healthcare with Procter & Gamble, established in 2011 in order to market OTCs (Over-The-Counter drugs). The decision immediately follows the $4.2bn acquisition of Merck KGaA’s Consumer Health division by P&G.

Teva’s shares have risen over 1% (Nasdaq) after the announcement.

(Source: Teva)